Texas Instruments: Paying full price for a restocking cycle that hasn't peaked yet

Stevie AI on Texas Instruments Incorporated (TXN-USA | texasinstrum)

9/1/2026

Summary

Texas Instruments is the second-largest analog semiconductor maker globally, running a vertically integrated 300mm manufacturing base across Richardson, Sherman, and Lehi that gives it a structural cost advantage over fabless peers like Analog Devices and ON Semiconductor. The core insight is that TI's current growth acceleration — from $15.6B revenue in FY2024 to a projected $24.3B by FY2029 — is being driven substantially by an industrial and automotive restocking cycle layered on top of secular content growth in data center power and auto electrification. The market is right to reward the recovery, but at $260.91 per share, the stock already discounts a smooth, uninterrupted march through this cycle with limited room for a demand air pocket. Recent actuals show the inflection clearly: revenue grew from $15.6B in FY2024 to $17.7B in FY2025, with EPS rising from $5.20 to $5.45 despite margin pressure from heavy depreciation tied to the capacity build-out. Net income grew more slowly than revenue (from $4.8B to $5.0B), reflecting the drag of rising D&A and ongoing capex intensity ($4.5–5.0B/year gross) even as the ITC benefit partially offsets cash costs. Management's own medium-term framework — $8–9B FCF at $20B revenue, scaling to $9–10B at $22B — implies FY2026-2027 sit in a transitional margin zone where utilization gains are real but not yet fully realized. Applying a 24x forward P/E — a premium-but-not-extreme multiple reflecting TI's structural cost advantage, capital return discipline, and diversified end-market exposure, but tempered by cyclicality and elevated capex — to the EPS path yields price targets of $151 (FY2026), $175 (FY2027), $199 (FY2028), and $222 (FY2029). These targets sit meaningfully below the current $260.91 price, implying the stock is pricing in either a higher sustained multiple or a faster margin recovery than the base case supports, hence a HOLD rating despite genuine long-term business quality.

Thesis

1. **Vertically Integrated Manufacturing as Durable Cost Advantage** — TI's 300mm U.S. fab footprint (Richardson, Sherman 1&2, Lehi 1&2) is the central differentiator versus fabless analog peers. This allows TI to internalize capacity decisions, capture ITC benefits (~35% on qualifying U.S. front-end capex), and maintain structurally lower unit costs as volumes scale. The cost advantage compounds with utilization — each incremental dollar of revenue against a largely fixed depreciation base flows through at higher incremental margin, which is precisely the mechanic behind the projected net income growth from $5.2B (FY2026) to $7.0B (FY2029) on revenue growth of only ~24% over that period. 2. **Cyclical Recovery Is Real But Already Substantially Reflected in Price** — Revenue reaccelerating from $17.7B to a guided high-single-to-low-double-digit FY2026 growth rate reflects genuine industrial and automotive restocking, a shift from just-in-time to just-in-case inventory philosophy among customers. However, this is a cyclical tailwind, not a structural rerating catalyst, and the stock's current valuation multiple already appears to assume the recovery sustains without a subsequent digestion phase — a pattern analog semis have exhibited in prior cycles (2018-2019, 2022-2023). 3. **Margin Recovery Trajectory Is Gradual, Not Explosive** — Gross margin expansion depends on factory utilization catching up to the capacity that's been built, but heavy ongoing capex ($4.5–5.0B annually) means D&A keeps rising in parallel. Net income growing from $4.8B (FY2024) to $7.0B (FY2029) — roughly 46% cumulative growth over five years — is respectable but not indicative of the kind of margin inflection that would justify paying a growth-stock multiple today. The FCF framework itself (management's $8-10B target band tied to $20-22B revenue) confirms this is a multi-year normalization, not a single catalytic event. 4. **Silicon Labs Acquisition Adds Complexity and Leverage Without Immediate Clarity on Returns** — The pending H1 2027 close, financed via cash and incremental debt, pushes net debt from $16.8B (FY2026) to $20.5B (FY2027) and further to $26.8B by FY2029. While this expands TI's addressable market (embedded connectivity), it also raises execution risk and leverage at a point in the cycle where industrial/auto demand normalization risk is elevated. The market has not yet fully priced integration risk or the incremental interest burden into estimates. 5. **Capital Return Program Is Disciplined But Constrained by Capex Priority** — The $1.42 quarterly dividend and $18.79B remaining buyback authorization signal continued shareholder-friendly capital allocation, but FCF generation ($3.4B in FY2026 growing to $5.5B by FY2029) must first fund $4.5-5.0B of annual capex before meaningfully accelerating buybacks. This constrains near-term per-share value creation relative to what the market may be assuming for a company trading at a premium multiple. 6. **Valuation Gap Signals the Market Is Pricing a Higher Multiple Than Warranted Today** — At $260.91, the stock trades well above the 24x forward P/E price targets derived from the EPS path, implying the market either expects faster margin recovery, a permanent step-change in secular growth (data center power content), or is applying a premium multiple in the high-20s to low-30s range. Absent clear evidence the restocking-driven growth is durable rather than cyclical, this gap represents the core mispricing risk for investors buying at current levels.

Risks

1. **Inventory Correction Risk** — The current demand strength is partly attributable to customers shifting from just-in-time to just-in-case inventory management. If end-customer demand normalizes or inventory levels prove excessive, TI could face a sharp reversal in bookings and utilization, similar to prior down-cycles in 2019 and 2023. 2. **Capex Intensity Pressures Near-Term FCF** — Sustained $4.5-5.0B annual gross capex, even with ITC offsets, constrains free cash flow conversion (FCF of only $3.4B against $5.2B net income in FY2026) and could pressure the balance of dividend growth versus buyback pace if the cycle disappoints. 3. **Silicon Labs Integration and Leverage Risk** — The acquisition financing raises net debt meaningfully (from $16.8B to $26.8B by FY2029) and integration risk is real; any execution missteps or dis-synergies would compound with cyclical demand risk to pressure the stock's premium multiple. 4. **Competitive Pricing Pressure from ADI and ON Semiconductor** — As a duopoly-adjacent market with strong competitors investing in their own capacity and pricing strategies, TI's pricing power could erode faster than modeled, particularly if a demand downturn triggers share-gain-motivated price competition. 5. **Multiple Compression Risk if Growth Decelerates** — Given the stock currently trades well above levels implied by a 24x forward multiple on the EPS path, any signs that FY2026-2027 growth is decelerating faster than guided (e.g., a miss versus the $5.65-6.15B Q3 2026 revenue guide) could trigger significant multiple compression on top of any earnings miss. 6. **Geopolitical and Tariff Exposure** — Despite the U.S.-based manufacturing advantage insulating TI from some geopolitical risk, global end-customer demand (especially China industrial/auto) remains exposed to trade policy shifts, tariff escalation, and broader macro slowdown risk that could disrupt the assumed restocking trajectory.

📈 Price Targets